glp-1 inventor GLP-1s are the most underhyped technology. New Conversations episode with Dave Ricks, CEO of Eli Lilly, out now. https://lnkd.in/gxApDsN9 | Scott Galloway Canadian scientist wins Breakthrough Prize

And the math hasnt worked for private insurance plans for a reason: it requires indefinite use with no stopping criteria, and theres a patent runway of 10+ years with no generic competition

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are being talked about everywhere for their weight-loss effects, but the conversation is evolving

Entrega super-rpida Faz a tua encomenda e recebe-a em 1 a 3 dias teis

O que

doi: 10.1016/s0196-9781(97)00016-8 91 FrieboesRMMurckHMaierPSchierTHolsboerFSteigerA

Another study, published in the American Journal of Ophthalmology, used health records from over 37 million people and found that GLP-1 drugs nearly doubled the five-year risk of developing optic nerve damage